Yehiel Tal
CEO
Claimed by owner CollPlant
Former names: CollPlant Holdings Ltd
Products and Technologies for Regenerative and Aesthetic Medicine
Public on NASDAQ Jan, 2018
CollPlant
techtime.co.il
•
Apr 10, 2023
ברחובות מפתחים מדפסת תלת-מימד לשתלי שד רגנרטיביים - Techtime - חדשות אלקטרוניקה והייטק
www.prnewswire.com
•
Nov 7, 2022
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90
www.prnewswire.com
•
Nov 3, 2022
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
www.prnewswire.com
•
Aug 25, 2022
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
www.prnewswire.com
•
Jun 29, 2022
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study
www.globes.co.il
•
Oct 31, 2021
היינן החוקר שמשתמש בצמח הטבק כדי לבנות איברים להשתלה
www.prnewswire.com
•
Mar 29, 2021
CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
www.prnewswire.com
•
Feb 8, 2021
CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
www.biospace.com
•
Sep 21, 2020
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant BioSpace
www.prnewswire.com
•
Sep 16, 2020
CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020
www.prnewswire.com
•
Sep 14, 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
www.prnewswire.com
•
Feb 14, 2020
CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement
www.prnewswire.com
•
Feb 10, 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
www.prnewswire.com
•
Feb 4, 2020
CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments
www.prnewswire.com
•
Jan 13, 2020
3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicine
www.prnewswire.com
•
Jan 6, 2020
CollPlant Partners in the Advanced Regenerative Manufacturing Institute
www.prnewswire.com
•
Oct 22, 2019
CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee
www.pharmiweb.com
•
Sep 3, 2019
https://www.pharmiweb.com/press-release/2019-09-03/collplant-biotechnologies-raising-55-million
www.prnewswire.com
•
Aug 5, 2019
CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue
officesnapshots.com
•
Jul 31, 2019
Office Tour: CollPlant Offices - Rehovot
www.calcalistech.com
•
May 23, 2019
CollPlant Opens New Israeli R&D Center
www.prnewswire.com
•
Apr 24, 2019
CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care
www.prnewswire.com
•
Mar 18, 2019
CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics
www.prnewswire.com
•
Mar 11, 2019
Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
www.prnewswire.com
•
Feb 19, 2019
CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body
www.prnewswire.com
•
Feb 4, 2019
CollPlant Announces Appointment of Jonathan M.N. Rigby as Chairman of the Board
www.prnewswire.com
•
Dec 10, 2018
Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow
www.prnewswire.com
•
Nov 12, 2018
CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
www.israel21c.org
•
Nov 4, 2018
3D bioprinted lungs to be available for global transplants
www.prnewswire.com
•
Oct 28, 2018
CollPlant Shares Will Be Traded From Tuesday Oct 30 Exclusively on Nasdaq
en.globes.co.il
•
Oct 22, 2018
Collplant soars on pact with United Therapeutics
www.prnewswire.com
•
Oct 22, 2018
CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
www.prnewswire.com
•
Aug 8, 2018
Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange
www.prnewswire.com
•
Apr 23, 2018
CollPlant Opens a New rhCollagen Production Facility
www.prnewswire.com
•
Feb 21, 2018
CollPlant Joins ReMDO's Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs
www.calcalistech.com
•
Jan 30, 2018
Tissue Regeneration Company CollPlant is Coming to Nasdaq
www.globes.co.il
•
Nov 12, 2017
Regenerative medicine co CollPlant raises $7.4m
3dprintingindustry.com
•
Oct 20, 2017
$5 million funding regenerates CollPlant's 3D printed organ development plans
www.globes.co.il
•
Sep 7, 2017
CollPlant raises $5m, to uplist on Nasdaq
ryortho.com
•
Jul 28, 2017
CollPlant's New BioInk May Transform Transplant Medicine
www.globes.co.il
•
Apr 2, 2017
CollPlant reports commercialization underway
www.globes.co.il
•
Nov 26, 2015
Trial result boosts CollPlant
www.globes.co.il
•
Jul 13, 2015
Tissue repair co Collplant jumps on US agreement
About
CollPlant is a regenerative and aesthetic medicine company developing technologies and products for tissue regeneration and organ manufacturing.
Primary Sector
Life Sciences & HealthTech
Products
Collink.3D 90, VergenixSTR, VergenixFG, Collage, Collink.3D 50
Geographic markets
Europe, United States
Funding
Total Funding
$60.5M
Market Cap
$79.4M
Last Funding
$4.5M
Funding Stage
Total Rounds
17
Investors
9
News
(43)
techtime.co.il
•
Apr 10, 2023
ברחובות מפתחים מדפסת תלת-מימד לשתלי שד רגנרטיביים - Techtime - חדשות אלקטרוניקה והייטק
www.prnewswire.com
•
Nov 7, 2022
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90
www.prnewswire.com
•
Nov 3, 2022
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
www.prnewswire.com
•
Aug 25, 2022
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
www.prnewswire.com
•
Jun 29, 2022
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study
www.globes.co.il
•
Oct 31, 2021
היינן החוקר שמשתמש בצמח הטבק כדי לבנות איברים להשתלה
www.prnewswire.com
•
Mar 29, 2021
CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
www.prnewswire.com
•
Feb 8, 2021
CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
www.biospace.com
•
Sep 21, 2020
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant BioSpace
www.prnewswire.com
•
Sep 16, 2020
CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020
www.prnewswire.com
•
Sep 14, 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
www.prnewswire.com
•
Feb 14, 2020
CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement
www.prnewswire.com
•
Feb 10, 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
www.prnewswire.com
•
Feb 4, 2020
CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments
www.prnewswire.com
•
Jan 13, 2020
3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicine
www.prnewswire.com
•
Jan 6, 2020
CollPlant Partners in the Advanced Regenerative Manufacturing Institute
www.prnewswire.com
•
Oct 22, 2019
CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee
www.pharmiweb.com
•
Sep 3, 2019
https://www.pharmiweb.com/press-release/2019-09-03/collplant-biotechnologies-raising-55-million
www.prnewswire.com
•
Aug 5, 2019
CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue
officesnapshots.com
•
Jul 31, 2019
Office Tour: CollPlant Offices - Rehovot
www.calcalistech.com
•
May 23, 2019
CollPlant Opens New Israeli R&D Center
www.prnewswire.com
•
Apr 24, 2019
CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care
www.prnewswire.com
•
Mar 18, 2019
CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics
www.prnewswire.com
•
Mar 11, 2019
Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
www.prnewswire.com
•
Feb 19, 2019
CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body
www.prnewswire.com
•
Feb 4, 2019
CollPlant Announces Appointment of Jonathan M.N. Rigby as Chairman of the Board
www.prnewswire.com
•
Dec 10, 2018
Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow
www.prnewswire.com
•
Nov 12, 2018
CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
www.israel21c.org
•
Nov 4, 2018
3D bioprinted lungs to be available for global transplants
www.prnewswire.com
•
Oct 28, 2018
CollPlant Shares Will Be Traded From Tuesday Oct 30 Exclusively on Nasdaq
en.globes.co.il
•
Oct 22, 2018
Collplant soars on pact with United Therapeutics
www.prnewswire.com
•
Oct 22, 2018
CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
www.prnewswire.com
•
Aug 8, 2018
Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange
www.prnewswire.com
•
Apr 23, 2018
CollPlant Opens a New rhCollagen Production Facility
www.prnewswire.com
•
Feb 21, 2018
CollPlant Joins ReMDO's Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs
www.calcalistech.com
•
Jan 30, 2018
Tissue Regeneration Company CollPlant is Coming to Nasdaq
www.globes.co.il
•
Nov 12, 2017
Regenerative medicine co CollPlant raises $7.4m
3dprintingindustry.com
•
Oct 20, 2017
$5 million funding regenerates CollPlant's 3D printed organ development plans
www.globes.co.il
•
Sep 7, 2017
CollPlant raises $5m, to uplist on Nasdaq
ryortho.com
•
Jul 28, 2017
CollPlant's New BioInk May Transform Transplant Medicine
www.globes.co.il
•
Apr 2, 2017
CollPlant reports commercialization underway
www.globes.co.il
•
Nov 26, 2015
Trial result boosts CollPlant
www.globes.co.il
•
Jul 13, 2015
Tissue repair co Collplant jumps on US agreement
The Team
(6)Eran Rotem
Deputy CEO & CFO
Oded Shoseyov
Founder, Chief Scientist
Ilana Belzer
COO
Philippe Bensimon
VP Regulatory Affairs and Quality Assurance
Michal Roytman Haham
Sales and marketing manager
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Public Offerings & Exits
Reverse Merger
EXIT
May 2010
Stock Exchange
TASE
Acquired Company
CollPlant
Public Offering
Undisclosed
Jan 2018
Stock Exchange
NASDAQ
Valuation
Undisclosed
Undisclosed
Delisting
Oct 2018
Stock Exchange
TASE
Private Equity Funding
Undisclosed Round
$1.5M
Sep 2006
$1.5M
Undisclosed Round
$2M
Feb 2007
1 Investors
$2M
Undisclosed Round
$4.5M
Apr 2007
1 Investors
$4.5M
Undisclosed Round
$8.3M
Apr 2008
1 Investors
$8.3M
Undisclosed Round
$3.8M
May 2010
$3.8M
Post-IPO Equity Funding
$5.5M
Dec 2010
$5.5M
Post-IPO Equity Funding
$1M
Feb 2012
2 Investors
$1M
Post-IPO Equity Funding
$2.8M
Nov 2012
2 Investors
$2.8M
Undisclosed Round
$2.5M
Oct 2013
1 Investors
$2.5M
Post-IPO Equity Funding
$6M
Nov 2013
$6M
Post-IPO Equity Funding
$2.2M
Nov 2015
$2.2M
Post-IPO Equity Funding
$3M
Feb 2017
2 Investors
$3M
Post-IPO Equity Funding
$5M
Sep 2017
1 Investors
$5M
Post-IPO Equity Funding
$2.4M
Nov 2017
$2.4M
Post-IPO Equity Funding
$5.5M
Sep 2019
$5.5M
Post-IPO Equity Funding
$4.5M
Feb 2020
$4.5M
Others
Academic Techonology
Aug 2004
undefined
3D Bioprinting for Regenerative Medicine
Media gallery
(5)
3D Bioprinted breast implants under development
3D bioprinted trachea using CollPlants BioInk. Courtesy of United Therapeutics and 3D systems
Trachea bioprinting
CollPlant's BioInk
rhCollagen Production
Locations
Israel
Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel
Locations
Israel
Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,